𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation by glucocorticoids of cell differentiation and insulin-like growth factor binding protein production in cultured fetal rat nasal chondrocytes

✍ Scribed by Reem Nadra; Pierrette Menuelle; Sylviana Chevallier; Ariane Berdal


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
340 KB
Volume
88
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Glucocorticoids (GCs) modulate insulin‐like growth factor action in cartilage through mechanisms that are complex and insufficiently defined, especially in the context of cranio‐facial growth. Because the family of IGF‐binding proteins (IGFBP‐1 to ‐6) is important in the regulation of IGF availability and bioactivity, we examined the effect of GCs on chondrocyte differentiation in correlation with IGFBP production in cultured fetal rat chondrocytes isolated from nasal septum cartilage of fetal rat. Dexamethasone (DEX) effects were tested before and at the onset of extracellular matrix maturation. DEX induced a dose‐dependent increase in the size of cartilage nodule formed, ^45^Ca incorporation into extracellular matrix, alkaline phosphatase activity, and sulfatation of glycosaminoglycans, maximal effects being obtained with a 10‐mM DEX concentration. The IGFBPs produced by cultured chondrocytes were characterized in culture medium which had been conditioned for 24 h under serum‐free conditions by these cells. Western ligand blotting with a mixture of [^125^I]IGF‐I and ‐II revealed bands of 20, 24, 29, a 31–32 kDa doublet and a 39–41 kDa triplet which were differently regulated by DEX. Immunoblotting showed that following DEX exposure, IGFBP‐3 and ‐6 were up‐regulated whereas IGFBP‐2, ‐5, and the 24 kDa band were down‐regulated. The effect of DEX on both differentiation and IGFBP production showed a same dependence, and developed when extracellular matrix maturation had been just induced. The results obtained in this chondrocyte culture system show that production of IGFBPs is modulated by DEX at physiological concentrations thus regulating IGF availability and action, a control which could promote the primordial role of the rat nasal septum in craniofacial growth. J. Cell. Biochem. 88: 911–922, 2003. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Insulin-like growth factor binding prote
✍ Yun Chen; Hong Shu; Changhua Ji; Sandra Casinghino; Kenneth Kim; Caren M. Gundbe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Insulin-like growth factor (IGF)-I and IGF-II are expressed at biologically effective levels by bone cells. Their stability and activity are modulated by coexpression of IGF binding proteins (IGFBPs). Secreted IGFBPs may partition to soluble, cell-associated, and matrix-bound compartments. Extracell

Down-regulation of insulin-like growth f
✍ Dae-Ghon Kim; Dae-yeol Lee; Baik-Hwan Cho; Kyung-Ran You; Mi-Young Kim; Deuk-Soo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

We observed that all-trans-retinoic acid (RA) down-regulated insulin-like growth factor binding proteins (IGFBPs) in cultured human hepatoma cells (Hep 3B, PLC/PRF/5, and Hep G2); therefore, we characterized the role of this down-regulation in cell growth. Treatment with 10 micromol/L RA revealed a

Prostaglandin E2 stimulates insulin-like
✍ J.A. Di Battista; S. Doré; N. Morin; Y. He; J.-P. Pelletier; J. Martel-Pelletier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

Insulin-like growth factor-1, IGF-1, is believed to be an important anabolic modulator of cartilage metabolism whose action is mediated by high affinity cell surface receptors and bioactivity and bioavailability regulated, in part, by IGF-1 binding proteins (IGFBPs). Prostaglandin E 2 (PGE 2 ) stimu

Regulation of insulin-like growth factor
✍ Su-Li Cheng; Shu-Fang Zhang; Subburaman Mohan; Fernando Lecanda; Aurora Fausto; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Glucocorticoids inhibit the proliferation, but induce the differentiation, of bone marrow stromal cells into osteoblast-like cells. The mechanisms, however, are still conjectural. Since insulin-like growth factors (IGFs) have profound effects on osteoblast growth and differentiation, it is possible

Osteogenic protein-1 regulates insulin-l
✍ Lee-Chuan C. Yeh; Martin L. Adamo; Cunming Duan; John C. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 2 views

Osteogenic protein-1 (OP-1 or BMP-7) stimulates new bone formation in vivo and induces cell proliferation and differentiation of osteoblasts in vitro. Previous studies from our laboratory revealed that OP-1 led to a two-to threefold increase in steady-state insulin-like growth factor-I (IGF-I) and I

Insulin-like growth factor binding prote
✍ Jennifer D. Lochrie; Kirsten Phillips; Elizabeth Tonner; David J. Flint; Gordon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

## Abstract We have previously demonstrated that insulin‐like growth factor binding protein‐5 (IGFBP‐5) is upregulated following treatment of the mouse mammary epithelial cell line HC11 with lactogenic hormones (dexamethasone, insulin, and prolactin—DIP). In addition, we have also shown that IGFBP‐